| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.55▼ | 1.56▼ | 1.57▼ | 1.62▼ | 1.56▼ |
| MA10 | 1.55▼ | 1.58▼ | 1.58▼ | 1.66▼ | 1.44▲ |
| MA20 | 1.56▼ | 1.59▼ | 1.60▼ | 1.60▼ | 1.44▲ |
| MA50 | 1.58▼ | 1.62▼ | 1.64▼ | 1.45▲ | 6.74▼ |
| MA100 | 1.59▼ | 1.65▼ | 1.61▼ | 1.44▲ | 10.63▼ |
| MA200 | 1.60▼ | 1.61▼ | 1.53▲ | 5.64▼ | 14.13▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.004▼ | -0.003▼ | -0.013▼ | 0.431▲ |
| RSI | 34.474▼ | 36.922▼ | 37.009▼ | 49.753▼ | 29.924▼ |
| STOCH | 33.333 | 6.397▼ | 27.647 | 53.031 | 67.353 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -70.114 | -36.364 |
| CCI | -117.681▼ | -129.825▼ | -160.494▼ | -30.440 | 85.252 |
|
Thursday, August 07, 2025 01:16 PM
SOUTH SAN FRANCISCO, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in integrin-based drug development, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 1.60 | 1.65 | 1.54 | 1.55 | 1,083,192 |
| 14/08/25 | 1.56 | 1.6094 | 1.45 | 1.575 | 2,729,752 |
| 13/08/25 | 1.68 | 1.71 | 1.55 | 1.60 | 2,378,095 |
| 12/08/25 | 1.672 | 1.71 | 1.64 | 1.68 | 849,774 |
| 11/08/25 | 1.61 | 1.72 | 1.608 | 1.70 | 1,091,243 |
| 08/08/25 | 1.56 | 1.71 | 1.54 | 1.66 | 811,689 |
| 07/08/25 | 1.70 | 1.745 | 1.6646 | 1.68 | 566,221 |
| 06/08/25 | 1.70 | 1.70 | 1.60 | 1.69 | 983,678 |
| 05/08/25 | 1.70 | 1.75 | 1.61 | 1.73 | 797,258 |
| 04/08/25 | 1.59 | 1.79 | 1.565 | 1.70 | 1,400,645 |
|
|
||||
|
|
||||
|
|